ASX 300

Australian companies are well known for their skills in digging up minerals, writing home loans, and selling groceries. But unfortunately for Australian investors,...

As we navigate the ever-evolving landscape of investment, data-driven strategies are emerging as the compass to navigate the challenges posed by rising bond yields,...

The daily Match Out for Monday 11 September 2023 from James Gerrish of Market Matters

We discuss the latest trends, surprises, and market insights, with a particular focus on the resilience of the Australian consumer.

Understanding all of the available energy options, including uranium, is essential to designing a balanced and future-ready portfolio.

AI is the tech on everyone's lips but it's more than the headlines when it comes to changing the world.

In this episode, IML's Michael O'Neill and Auscap Asset Management's Will Mumford run the ruler over the August reporting season.

The daily Match Out for Friday 8 September 2023 with James Gerrish of Market Matters

Learn how Stefan is using dollar-cost averaging to increase the value of his savings and produce passive income.

Warren Buffett has a soft spot for Japanese trading firms. But how does that tie into Macquarie?

Orora is not exactly shy about pursuing acquisitions. But will this one sit well with shareholders?

Get up to date on overnight market activity and the big events for the day.

And a few ideas with strong momentum behind them backed by one of the country's finest fund managers.

Plus, Coda finds enhancements of its own at South Australian copper project and Evion finds fans amid forecasts of graphite shortfall.

Experienced investors told us they enjoy researching companies and turning insights into trading decisions.  As Livewire Live’s 2023 principal sponsor, Bell Direct is...

Canadian lithium projects are white hot right now, and for good reason. We breakdown why, the risks and our top pick in the sector.

The daily Match Out for Thursday 7 September 2023 with James Gerrish of Market Matters.

Equity markets are pricing a continuation of the status quo, with technology and perceived growth continuing to dominate investor attention.

Morgan Stanley released its Post-result and FY24 Outlook for Australian Healthcare with a number of changes.

Get up to date on overnight market activity and the big events for the day.

How much of the AI hype is justified? And what is more important to investing: imagination or scepticism?

The daily Match Out for Wednesday 6 September with James Gerrish of Market Matters.

Despite NVIDIA soaring around 240% in 2023, Griffin argues the stock is cheaper than it's been in a year.